Acorah Software Products - Accounts Production 16.8.200 false true 31 August 2024 1 September 2023 false true No description of principal activity 1 September 2024 31 August 2025 31 August 2025 12816961 Dr Martin Toal iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12816961 2024-08-31 12816961 2025-08-31 12816961 2024-09-01 2025-08-31 12816961 frs-core:CurrentFinancialInstruments 2025-08-31 12816961 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12816961 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 12816961 frs-bus:Micro-entities 2024-09-01 2025-08-31 12816961 frs-bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 12816961 frs-bus:Director1 2024-09-01 2025-08-31 12816961 2023-08-31 12816961 2024-08-31 12816961 2023-09-01 2024-08-31 12816961 frs-core:CurrentFinancialInstruments 2024-08-31
Registered number: 12816961
Conan Biopharma Consulting Ltd
Unaudited Financial Statements
For The Year Ended 31 August 2025
Accountwise Ltd
Conan Biopharma Consulting Ltd
Accountant's Report
For The Year Ended 31 August 2025
Accountant's Report
Chartered Accountant's report to the director on the preparation of the unaudited statutory accounts of Conan Biopharma Consulting Ltd for the year ended 31 August 2025
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Conan Biopharma Consulting Ltd for the year ended 31 August 2025 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the director of Conan Biopharma Consulting Ltd , as a body, in accordance with the terms of our engagement letter dated 08 December 2020. Our work has been undertaken solely to prepare for your approval the accounts of Conan Biopharma Consulting Ltd and state those matters that we have agreed to state to the director of Conan Biopharma Consulting Ltd , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Conan Biopharma Consulting Ltd and its director, as a body, for our work or for this report.
It is your duty to ensure that Conan Biopharma Consulting Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Conan Biopharma Consulting Ltd . You consider that Conan Biopharma Consulting Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of Conan Biopharma Consulting Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.

17/02/2026

Accountwise Ltd
198 Finchampstead Road
Wokingham
Berkshire
RG40 3HB
Page 1
Conan Biopharma Consulting Ltd
Balance Sheet
As At 31 August 2025
Balance Sheet
Registered number: 12816961

| 2025 | 2024
--- | --- | ---
|  | £ | £
Current assets |  | 61,699 | 17,047
Creditors: Amounts Falling Due Within One Year |  | (44,238 ) | (16,172 )
NET CURRENT ASSETS |  | 17,461 | 875
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 17,461 | 875
NET ASSETS |  | 17,461 | 875
CAPITAL AND RESERVES |  | 17,461 | 875

## Notes

1. General Information
Conan Biopharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12816961 . The registered office is Windrush School Road, Barkham, Wokingham, RG41 4TN.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Martin Toal Director
17/02/2026